N-of-1 trials and integrative oncology | Dr Jean-Lionel Bagot & Dr Ingrid Theunissen

Oncologists Dr Jean-Lionel Bagot and Dr Ingrid Theunissen discuss the work they presented at HRI London 2023, which explores the concept of N-of-1 trials in the context of homeopathy and integrative oncology.

N-of-1 trials aim to identify what works for a particular patient, rather than relying solely on double-blind randomised controlled trials (RCTs), in order to help establish optimal outcomes in a real-world setting.

[pgiqrok]

For Homeopathy, N of 1 implies justifying anecdotes as evidence. Homeopathy isn't personalized medicine, it is personalized fantasy.